UBS O'Connor’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Sell |
52,975
-75,713
| -59% | -$616K | 0.02% | 252 |
|
|
2025
Q1 | $1.01M | Buy |
128,688
+52,042
| +68% | +$409K | 0.03% | 175 |
|
|
2024
Q4 | $1.14M | Buy |
76,646
+44,784
| +141% | +$667K | 0.03% | 209 |
|
|
2024
Q3 | $487K | Sell |
31,862
-33,325
| -51% | -$510K | 0.01% | 334 |
|
|
2024
Q2 | $993K | Buy |
65,187
+1,065
| +2% | +$16.2K | 0.03% | 293 |
|
|
2024
Q1 | $1.21M | Buy |
64,122
+10,876
| +20% | +$205K | 0.03% | 254 |
|
|
2023
Q4 | $1.02M | Sell |
53,246
-46,166
| -46% | -$882K | 0.03% | 262 |
|
|
2023
Q3 | $1.78M | Sell |
99,412
-5,000
| -5% | -$89.8K | 0.03% | 260 |
|
|
2023
Q2 | $2.12M | Sell |
104,412
-10,068
| -9% | -$204K | 0.04% | 283 |
|
|
2023
Q1 | $2.09M | Buy |
+114,480
| New | +$2.09M | 0.05% | 304 |
|
|
2022
Q4 | – | Sell |
-38,725
| Closed | -$1.01M | – | 246 |
|
|
2022
Q3 | $1.01M | Sell |
38,725
-11,700
| -23% | -$306K | 0.01% | 736 |
|
|
2022
Q2 | $1.28M | Buy |
+50,425
| New | +$1.28M | 0.01% | 728 |
|